Elevating Australia's Scientific Acumen: Large Molecule Facility Doubles Size of Australia's Top Bioanalytical Laboratory
May 12, 2022 15:00 HKT |  |
|
Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials
May 12, 2022 06:00 HKT |  |
|
Novotech Acquires US CRO NCGS, Expands Global Expertise
May 05, 2022 09:00 HKT | |
|
Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 - Best Contract Research Organization in APAC
Apr 19, 2022 10:00 HKT |  |
|
Avance Clinical Announces New Office Opening in Melbourne
Mar 31, 2022 15:00 HKT | |
|
Avance Clinical Announces New Office Opening in Sydney
Mar 02, 2022 15:00 HKT | |
|
Therapeutic Goods Administration of Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years)
Feb 17, 2022 10:45 HKT |  |
|
Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries
Feb 16, 2022 07:00 HKT | |
|
Novotech Recognized as Top 10 CRO in CenterWatch Global Site Relationship Benchmarking Report
Feb 09, 2022 15:00 HKT | |
|
Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022
Jan 18, 2022 13:00 HKT | |
|
Apollomics Inc. to Host Virtual Investor Events on Wednesday, January 26, 2022 and Thursday, January 27, 2022
Jan 12, 2022 09:25 HKT |  |
|
B-cell lymphoma clinical trials now open on the TrialWire Platform
Jan 05, 2022 17:10 HKT |  |
|
Autism clinical trials now open on the TrialWire Platform
Jan 05, 2022 17:00 HKT | |
|
Apollomics Inc. Announces CEO Guo-Liang Yu, PhD Appointed as Chairman of the Board for the BayHelix Group
Jan 04, 2022 10:10 HKT | |
|
Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial with APL-106 (Uproleselan Injection) in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia
Nov 22, 2021 10:40 HKT | |
|
Olympus Launches Venture Capital Fund to Strengthen Medtech Leadership
Nov 12, 2021 07:30 HKT |  |
|
Agilex Biolabs Shares How to Select the Right Bioanalytical Tools for Immuno-oncology and Vaccines Studies - OCT Webinar
Oct 19, 2021 15:00 HKT | |
|
Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain
Oct 19, 2021 15:00 HKT | |
|
Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox
Oct 14, 2021 14:45 HKT |  |
|
Edison Oncology and Apollomics Announce Treatment of First Patient by EO1001 (APL-122) in a Phase I/IIa Clinical Trial
Oct 01, 2021 10:00 HKT |  |
|